PuraCath Medical
  • Home
  • About Us
    • PuraCath
    • Management Team
    • Board of Directors
    • Advisory Board Members
  • Technology
  • Patients
    • Peritoneal Dialysis
    • Vascular Access
  • Events
  • News
  • Contact
  • Search
News
You are here: Home / News / News / The MedTech Strategist: PuraCath Medical, Anti-infection Device Enables...

The MedTech Strategist: PuraCath Medical, Anti-infection Device Enables Greater Access to Peritoneal Dialysis

October 22, 2015/in News /by puracath

We are excited to announce that PuraCath Medical is listed as a start-up to watch in the latest volume of the MedTech Strategist published on October 16th.  Please read the full article here.

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on Linkedin
  • Share by Mail

Recent Posts

  • PuraCath Medical Receives 510(k) Clearance for its Needleless Connector for Vascular Access
  • Why We Aren’t Using UV to Disinfect Everything—Yet
  • PuraCath UV Device Displays a 99.9999% Disinfection of COVID-19 Virus in 1 Second
  • PuraCath FireflyTM Can Kill Deadly Microorganisms with UV Light, Like SARS CoV-2
  • PuraCath Medical Shows Greater Than 99.99% Reduction in ‘Superbug’ Candida Auris with One Second of UVC Exposure
© Copyright - PuraCath 2017
  • E-Mail Updates
  • Terms of Use
PuraCath Medical Presents Data on the Company’s Proprietary Infection Reduction... PuraCath Medical Receives 510(k) Clearance for the FireFly™ Peritoneal Dialysis...
Scroll to top